Low-Dose Immunotherapy has made immunotherapy more accessible, and has brought down the cost of therapy from 60-80 lakhs to below 5.0 lakhs per year. Hugh cost saving. A step towards atmanirbhar Bharat. @PMOIndia@TOIIndiaNews@ndtv@ZeeNews@the_hindu https://t.co/c0WuC9Wlfk
It might be only time that we have received a letter from JCO congratulating our this paper as it was discussed a lot on social media. Interest generated suggests that this would get adapted in practice. @Amolpatel_dr@oncology_bg@ecancer@VanitaNoronha https://t.co/za2bJ5WjKg